High ANKZF1 expression is associated with poor overall survival and recurrence-free survival in colon cancerVisa övriga samt affilieringar
2019 (Engelska)Ingår i: Future Oncology, ISSN 1479-6694, E-ISSN 1744-8301, Vol. 15, nr 18, s. 2093-2106Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Aim: To investigate the association and prognostic value of ANKZF1 gene for survival in colorectal cancer, the mechanism of ANKZF1 level alteration and correlated signaling pathways ANKZF1 is involved. Patients amp; methods: The Cancer Genome Atlas COREAD dataset was analyzed by bioinformatical investigation. Results: High ANKZF1 expression is associated with poor overall survival (hazard ratio [HR]: 2.094; 95% CI: 1.188-3.689; p=0.011) and recurrence-free survival (HR: 1.762; 95% CI: 1.021-3.042; p=0.042) in colon cancer. Bioinformatical analysis showed ANKZF1 was upregulated by amplification and exon expression. ANKZF1 was associated with angiogenesis and cancer signaling pathways. Conclusion: High ANKZF1 is an independent factor of poor survival (overall survival and recurrence-free survival) in colon cancer by taking part in angiogenesis and some cancer signaling pathways.
Ort, förlag, år, upplaga, sidor
FUTURE MEDICINE LTD , 2019. Vol. 15, nr 18, s. 2093-2106
Nyckelord [en]
ANKZF1; colon cancer; OS; overall survival; recurrence-free survival; RFS; WGCNA
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
URN: urn:nbn:se:liu:diva-160630DOI: 10.2217/fon-2018-0920ISI: 000485097700004PubMedID: 31257922OAI: oai:DiVA.org:liu-160630DiVA, id: diva2:1360198
Anmärkning
Funding Agencies|Natural Science Foundation of ChinaNational Natural Science Foundation of China [81402446]; Research Foundation of Health and Family Planning Commission of Sichuan Province [150136]
2019-10-112019-10-112019-10-11